RxUniverse Pilots Earn Rx.Health Award for Top Evidence-Based Study

New York, NY -- (ReleaseWire) -- 01/05/2018 -- On Dec 5, Rx.Health was honored for the top evidence-based study as it received the "From Innovation to Transformation" Award at NODE Health's inaugural Digital Medicine Conference. The award followed presentations around the usability and clinical application of RxHealth's flagship product, RxUniverse, by CEO Ed Berde and VP of Corporate Development Pavan Choksi, and was presented by Victoria Taise, Director of Informatics Strategy at New York-Presbyterian Hospital.

"As a data-driven company, receiving this type of recognition from an organization that serves as the academic home of evidence in Digital Medicine is equal parts validating and humbling," Berde said. "On the day-to-day, our mission statement is focused on improving patient care through clinically-proven digital solutions. When you receive an award like this from an organization such as NODE Health, you take a moment to pause and realize that others recognize the importance and validity of what you do."

Choksi presented the results of the RxUniverse study at the Mount Sinai Health System, which resulted in RxUniverse's ranking in the 96th percentile on Usability.gov's System Usability Scale and exceeded digital prescription expectancies by more than 200 percent. The results of the pilot were previously presented at the American Medical Informatics Association's 2017 Annual Symposium in Washington, DC.

Berde presented the results of a second project focused on patients who were prescribed remote monitoring through the RxUniverse platform to manage Chronic Heart Failure. The quality improvement project, conducted at the Mount Sinai Hospital, found that patients monitoring their condition through a smartphone app and connected health devices, monitored by a population health coordinator, were less likely to be readmitted to the hospital. Among participants, the readmission rate during the 30-day window when hospitals are at risk for readmission penalties was just 10 percent, a dramatic statistic when compared to the national average of 25 percent.

"There currently exists a tremendous need for guiding and engaging heart failure patients post-discharge," said Sean Pinney, MD, who serves as the Director of Advanced Heart Failure and Cardiac Transplantation at Mount Sinai. "User variables are having a high impact on patient populations, so we look forward to scaling these technologies."

The annual conference, the first to focus on the science of evidence-based Digital Medicine, hosted more than 300 of the leading innovators in digital health at the Microsoft Technology Center in Times Square. The event featured panel discussions, speeches and presentations from some of the leading minds in the digital health space, and provided critical insight into the future of Digital Medicine.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dusseldorf, Germany -- (ReleaseWire) -- 11/14/2017 -- Rx.Health's RxUniverse was selected as one of the top 15 app-based medical solutions worldwide in advance of the 2017 MEDICA App Competition, organized at the world's leading trade fair for the medical industry. In order to be considered, apps must be novel, solve a large unmet need, scalable across countries and must pass the scrutiny from the conference's jury panel. This year's panel was comprised of nearly a dozen leading healthcare leaders and innovators around the globe.

On Nov. 15, Rx.Health CEO Ed Berde will travel to Dusseldorf, Germany to present at the conference and meet with leaders from health systems, payers and pharma interested in bringing innovation through RxUniverse unique platform approach that can integrate multiple solutions under one workflow.

When asked about this year's inclusion, Berde stated that "It is quite an honor to present at MEDICA. This is further validation for RxUniverse and how it can harness the power of tremendous innovation happening worldwide and transform care by integrating and delivering those solutions to the hands of patients at right time to deliver the right outcomes. Our selection at MEDICA speaks to a global appeal for this platform and we will be looking to further expand on our meaningful partnerships with key international players."

The Conference attracts the world's leading technology and healthcare companies as exhibitors, as Sony Europe, Samsung, and Medtronic Inc. will be in attendance. Focal topics for this year include wearable technology in sports and healthcare, enabling technology for healthcare devices, patient centered IoT solutions, healthcare certification and standards, and disruptive technologies in healthcare.

Rx.Health's nomination comes shortly after an exciting presentation at the American Medical Informatics Association Annual Symposium, which documented RxUniverse's 96th percentile score on the System Usability Scale established by the U.S. Department of Health & Human Services' Usability.gov, a leading resource for user experience, best practices and guidelines serving practitioners in the government and private sectors.

Rx.Health's RxUniverse Platform is changing the model for patient care by allowing practitioners to automate best practices within a health system or payer organization and extend treatment outside of the clinical setting. Rx.Health curates Digital Medicine solutions that are clinically proven to enhance patient outcomes, which in turn lowers costs for health systems as they transition to value-based care. The Platform provides a uniquely intuitive and efficient prescription mechanism built right into a health system's EHR.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Study results featured at American Medical Informatics Association Annual Symposium

Washington, D.C. -- (ReleaseWire) -- 11/09/2017 -- Rx.Health's Digital Medicine App-Prescribing Platform, RxUniverse™, received a 96th percentile score on the System Usability Scale established by the U.S. Department of Health & Human Services' Usability.gov, a leading resource for user experience (UX) best practices and guidelines serving practitioners in the government and private sectors. The results were obtained over an eight week study conducted at the Mount Sinai Health System.

The study, which included five clinical sites, aggregated data from care teams across multiple specialties. Clinicians completed the SUS Questionnaire, which measured the success of the RxUniverse™ platform based on usability and learnability. The tool, provided by Usability.gov, managed by the Digital Communications Department of the U.S. Department of Health and Human Services Office, contained 10 predetermined statements which each required a response on how strongly the subject agreed or disagreed with the statement, with a response of 1 representing strong disagreement and a response of 5 indicating the subject strongly agreed with the statement. Clinicians' responses were converted to a 0 to 100 scale as per SUS Guidelines and scored by comparing the results to the provided rating scales. RxUniverse's™ 84.2 score ranked in the 96.2 percentile of usability for technology products. A score of 68 is considered to be an average score across all categories on the System Usability Scale and other health apps considered of respectable usability typically report scores in the 70's.

Research shows that the System Usability Scale provides a reliable measure of usability and user satisfaction. The performance of Rx.Health's RxUniverse™ Platform on this scale, combined with the clinically-proven Digital Medicine apps prescribed by clinicians during the study, provides health systems with a complete solution for engaging validated health technology for their patients.

Sonya Makhni, MD, MBA a physician at the University of Michigan and a graduate of the Massachusetts Institute of Technology and Harvard Business School, led the study at the Mount Sinai Health System. Dr. Makhni gave an exciting and robust presentation detailing the results of Rx.Health's RxUniverse™ use over the course of the study. The presentation took place during the American Medical Informatics Association's Annual Symposium, the premiere healthcare informatics conference. Dr. Makhni presented RxUniverse's™ impact to health systems in evaluating health tech app quality, specifically, evaluating efficacy, overcoming the lack of peer-review studies, avoiding unsubstantiated claims, and ensuring effectiveness and patient outcome results. Dr. Makhni also presented the effectiveness of Rx.Health's RxUniverse™ platform in the dissemination of interventions to patients, avoiding the burdens placed on patients in adopting Digital Medicine solutions, and ensuring ongoing utilization and visibility into patient health outside of the health system.

Prior to Dr. Makhni's presentation, Ashish Atreja, MD, the Chief Innovation Officer, Medicine at the Mount Sinai Health System, spoke about the impact of the RxUniverse™ study. "AMIA is the perfect event to present the results of the RxUniverse™ study. Mount Sinai Health System is proud to be the first health system in the country where providers can prescribe apps and a high usability score shows the power of a simplified workflow to bring revolutionary tools into the hands of providers and patients," said Dr. Atreja.

Rx.Health's flagship RxUniverse™ platform was created to solve two major complications that have arisen as a result of the rapid proliferation of mobile health apps: (1) the absence of standardization to evaluate digital health solutions, and (2) the inability for providers to ensure that patients adopt the correct recommended solution. For clinicians, the RxUniverse™ Platform creates an ecosystem that promotes evidence-based review of the most effective Digital Medicine. RxUniverse™ is changing the model for patient care by allowing practitioners to extend treatment outside of the clinical setting, which in turn lowers costs for health systems as they transition to value-based care.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

In recognition of World Mental Health Day and the importance of changing the Country’s narrative on mental health, Rx.Health and BrainCheck are proud to announce a strategic partnership focused on providing cognitive benefits to patients

New York, NY -- (SBWIRE) -- 10/10/2017 -- In recognition of World Mental Health Day and the importance of changing the Country's narrative on mental health, Rx.Health and BrainCheck are proud to announce a strategic partnership focused on providing cognitive benefits to patients through digital therapeutics. World Mental Health Day was established in 1992 to advocate against the social stigma surrounding mental health issues and raise awareness of mental health education worldwide.

BrainCheck's products will now be fully integrated onto Rx.Health's RxUniverse Digital Medicine Prescribing Platform, which enables physicians to prescribe evidence-based mobile apps, multi-media education, wearables, and customized care plans for various diseases, procedures and surgeries at the point of care. BrainCheck's digital technologies provide doctors and patients with a comprehensive understanding of the brain to assess brain performance with innovative neurocognitive testing.

"Through our partnership with Rx.Health, we are now able to reach thousands of patients and providers in healthcare systems around the world," said Dr. Yael Katz, co-founder and CEO of BrainCheck. "This signals a substantial step toward delivering on our promise of making a cognitive health assessment a routine part of healthcare."

Experts estimate that up to 40 percent of people with Alzheimer's disease suffer from depression. Cognitive impairment and mental health conditions often go hand-in-glove, with depression leading to difficulty "thinking" and impaired cognition leading to depression. Because both cognitive and psychiatric conditions can lead to decreased quality of life, it is critical to assess cognitive function in all mental health patients.

BrainCheck was conceptualized and spun out of the Baylor College of Medicine, where co-founder Dr. David Eagleman pioneered the vision of empowering patients to take control of their cognitive health with intuitive, interactive assessments. Widely recognized as a visionary in the field of neuroscience for over 20 years, Dr. Eagleman is also a New York Times best-selling author, a TED speaker, and the creator and host of the Emmy-nominated PBS series "The Brain." "You get a clear picture of your body's health with a visit to the doctor, but no measure at all of your brain health," said Eagleman. "BrainCheck allows people to get a clear picture of their cognitive function through time."

"If you've got your toe in the water of Digital Medicine, you're aware that the application of digital therapeutics to cognitive wellness is tremendous and absolutely necessary," said Pavan Choksi, who heads corporate development at Rx.Health. "BrainCheck not only represents the gold standard in this space, but also shares a similar ethos with Rx.Health as a data-driven company born out of a top academic medical center."

About Rx.Health
Rx.Health is defining the delivery of Digital Medicine. Formerly Responsive Health, a spinoff from the Mount Sinai Health System, Rx.Health is dedicated to facilitating the digital revolution in healthcare. Rx.Health's flagship product, RxUniverse, is the first enterprise-based Digital Medicine delivery system that enables physicians to prescribe evidence-based mobile health applications, multi-media education, wearables, and digital therapeutics to patients at the point of care.

Information on Rx.Health and RxUniverse is available at http://Rx.Health and http://RxUniverse.com, or follow Rx.Health on Twitter @Rx_Health and LinkedIn at https://www.linkedin.com/company/Rx-Health.

About BrainCheck
BrainCheck's goal is to democratize cognitive health by bringing its interactive testing platform to people everywhere. Available on iPhone, iPad and desktop, in English and Spanish, BrainCheck assesses multiple cognitive domains in minutes and delivers results that can be shared with family members, caregivers, and clinicians. BrainCheck is used by individuals, athletic teams, senior organizations, and doctors around the world, and is spreading rapidly. The platform also includes special content by renowned neuroscientist, author and speaker Dr. David Eagleman to give people insights into the inner workings of the brain and a better understanding of their brain health.

To learn more, please visit http://www.braincheck.com.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Toolkit will enable healthcare providers to improve quality of care, increase patient engagement and maximize their MIPS score with minimal disruption to their existing workflows

New York, NY -- (SBWIRE) -- 09/29/2017 -- MyMipsScore and Rx.Health announced a strategic partnership today to deliver next-generation quality improvement solutions for healthcare providers to excel under value-based reimbursement models. All existing users of MyMipsScore and Rx.Health will have the option to upgrade to the new release.

MyMipsScore offers a unique tool designed to understand, calculate, analyze and maximize the MIPS score. MyMipsScore Patent Pending MIPS Score Simulator enables organizations to analyze all 271 quality measures and compare them across all benchmarks in real time. MyMipsScore also includes ACI and IA performance scores to calculate your Composite Performance Score (CPS) commonly known as MIPS Score and the estimated payment adjustment.

Through the RxUniverse prescription platform, Rx.Health is providing the solution for practitioners to embrace Digital Medicine as they adapt to value-based care. RxUniverse aggregates the most effective Digital Medicine solutions available on the market onto a single platform, allowing healthcare organizations and their care teams to engage with patients and prescribe evidence-based mobile health applications, multi-media education, wearables, and therapeutics at the point of care.

"MyMipsScore's vision from the beginning has been to provide a solution that enables healthcare providers to understand value-based reimbursement programs and make informed strategic decisions," said Dr. Pawan Jindal, Founder of MyMipsScore. "Aligning with a partner that is recognized as a leader in Digital Medicine will empower our users to implement interventional programs with minimal effort to execute those decisions."

Most practitioners are focused on avoiding the penalty, they are not aware of the potential bonus they can earn under MIPS. This bonus can be realized, and penalties can be avoided, by engaging the Digital Medicine toolkit provided through the RxUniverse platform. The platform can be utilized to automate quality activities such as those that (1) gather patient experience data to improve practices, (2) provide online scheduling, and (3) support appointment reminders and transitions of care. Coupled with the analytics provided by the MIPS Score Simulator, the joint offering by MyMipsScore and Rx.Health provides a single solution for practitioners to capitalize on providing high-quality care to patients.

"Even though maximizing a MIPS score has potential to provide substantive rewards for providers, most practitioners are completely unprepared for the fast-approaching October deadline," said Rx.Health CEO Ed Berde. "By partnering with MyMipsScore, we are able to immediately and seamlessly provide clinicians with a complete toolkit to take full advantage of reimbursements while avoiding needless penalties as we move into 2018."

About MyMipsScore LLC
MyMipsScore is a healthcare technology company focused on helping clients achieve their goals through highly customized, end-to-end People Compatible software solutions. More information at http://www.mymipsscore.com

About Rx.Health
Rx.Health is defining the delivery of Digital Medicine. Formerly Responsive Health, a spinoff from the Mount Sinai Health System, Rx.Health is dedicated to facilitating the digital revolution in healthcare. Rx.Health's flagship product, RxUniverse, is the first enterprise-based Digital Medicine delivery system that enables physicians to prescribe evidence-based mobile health applications, multi-media education, wearables, and therapeutics to patients at the point of care. Information on Rx.Health and RxUniverse is available at http://Rx.Health and http://RxUniverse.com, or follow Rx.Health on Twitter @Rx_Health and LinkedIn at https://www.linkedin.com/company/Rx-Health.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Secaucus, NJ -- (SBWIRE) -- 05/31/2017 -- In conjunction with the World Health Organization's World No Tobacco Day, recognized every year on May 31, Responsive Health™, the company defining Digital Medicine, and Click Therapeutics™, the leading provider of smoking cessation solutions, have announced a strategic partnership to integrate the Clickotine® smoking cessation app onto the RxUniverse prescription platform.

"Responsive Health™ is defining Digital Medicine by prescribing clinically-proven applications and therapeutics to patients at the point of care," said Pavan Choksi, VP of Corporate Development at Responsive Health™. "By partnering with Click, we are empowering health systems and patients to engage with the clinically-proven Clickotine® app to break a habit that so many Americans struggle with on a daily basis."

According to the Center for Disease Control and Prevention, cigarette smoking is the leading cause of preventable death, attributing to more than 480,000 deaths per year in the United States. The CDC also reports that 70 percent of American smokers want to quit, but that only six percent of those who tried to quit without the help of medicine or counseling were successful.

During Clickotine®'s eight-week clinical trial, nearly half of the participants had stopped smoking by the end of the study. After following up at the six-month mark with smokers who participated in the clinical trial, more than a third of participants had completely quit smoking for at least 30 days.

Clickotine® is proven to help patients stop smoking by utilizing personalized strategies and data driven "quit plans," which monitor progress over time and provide telemedicine consultations. The app also helps reduce nicotine cravings with controlled breathing exercises and digital diversions, including games and activities.

"We are delighted to partner with Responsive Health™ to integrate Clickotine® onto the RxUniverse prescription platform. It reinforces the value of conducting rigorous clinical studies to prove best in class engagement and efficacy for our Digital Therapeutics," said Joel Sangerman, Chief Commercial Officer at Click Therapeutics™.

Responsive Health™ and Click Therapeutics™ are proud to partner together to snuff out smoking on World No Tobacco Day.

About Responsive Health™
Responsive Health™ is defining Digital Medicine. Responsive Health's™ flagship product, RxUniverse™, is the first enterprise-based digital health delivery system that enables physicians to prescribe evidence-based mobile health applications, wearables and therapeutics to patients at the point of care. More information about Responsive Health™ is available at ResponsiveHealth.org or on Twitter @ResponsiveHlth.

About Click Therapeutics™
Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavioral modification. Click Therapeutics™ digital interventions enable change within individuals, and can be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to drive cognitive and behavioral outcomes. For more information, visit ClickTherapeutics.com.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Secaucus, NJ -- (SBWIRE) -- 05/24/2017 -- On May 23, a study published by the market leading research company Maru/Matchbox confirmed that more than three quarters of hospital-related physicians are receptive to utilizing Digital Medicine in their practices. The same study also claimed that more than two thirds of patients are also eager to use Digital Medicine as a means to better care.

These statistics confirm Dr. Ashish Atreja's vision in co-founding Responsive Health and launching its flagship product RxUniverse, the first-to-market prescription platform bringing Digital Medicine to health systems and patients at the point of care.

"Over a decade ago, we saw the need for continual care that extended beyond a patient's office visit," said Dr. Atreja. "Numbers indicating the majority of patients and healthcare providers are now embracing Digital Medicine is so thrilling, that's why Responsive Health was first to seize the opportunity and why we believe health systems across America view Prescribing Digital Medicine as a key component of their practice."

The same Maru/Matchbox Healthcare Industry Study further echoed Dr. Atreja's sentiments on improving patient satisfaction and increasing overall efficiencies.

The benefits of Digital Medicine are clear for patients. Digital Medicine literally puts healthcare in the patient's hand through mobile health apps curated by RxUniverse's sophisticated evaluation matrix, which assesses apps based on clinical trials, HIPAA compliance, and more.

In addition to his role as co-founder of Responsive Health, Dr. Atreja has been working to pioneer Digital Medicine for the past decade first as a physician at the Cleveland Clinic, where he served as an informatics fellow. He then joined Mount Sinai Health System as the Chief Innovation and Engagement Officer of Medicine. Dr. Atreja runs the Sinai App Lab where the RxUniverse Digital Medicine Prescription Platform was originally created. Dr. Atreja also runs NODE Health, a consortium of over 20 health systems. NODE Health, the Network of Digital Evidence, focuses on the evidence required for Health Systems to collaboratively adopt Digital Medicine solutions.

About Responsive Health
Responsive Health™ is defining the delivery of digital medicine. Founded as a spinoff from the Mount Sinai Health System, a seven-hospital health system in New York City and a driving force in the rapid technological innovations in healthcare, Responsive Health™ is dedicated to enabling the digital revolution in health. Responsive Health's™ flagship product, RxUniverse™, is the first enterprise-based digital health delivery system that enables physicians to prescribe evidence-based mobile health applications, wearables and therapeutics to patients at the point of care.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Leader in Digital Medicine Will Attend April 27 Event

New Brunswick, NJ -- (SBWIRE) -- 04/24/2017 -- Responsive Health, a Mount Sinai spinoff and the leader in Digital Medicine, has been selected to attend the New Jersey Founders and Funders event in North Brunswick, N.J. on Thursday, April 27.

The event is organized by the New Jersey Economic Development Authority's Technology and Life Sciences team and serves to aid growth in emerging New Jersey technology and life sciences companies by facilitating introductions to sophisticated investors.

"New Jersey Founders and Funders is a premier event connecting fast growing tech companies like Responsive Health with investors," said Pavan Choksi, the Vice President of Corporate Development at Responsive Health. "We're excited that we were selected to attend, and look forward to further expanding our network in the New Jersey market."

The New Jersey Founders and Funders event invites venture capital firms and institutional investors to meet select companies for one-on-one strategy sessions. The companies present their business models and technology to capture potential funding opportunities.

The April 27 session will be Responsive Health's first time attending the event and coincides with the company's recent entry into the New Jersey healthcare market.

About Responsive Health
Responsive Health is defining the delivery of digital medicine. Founded as a spinoff from the Mount Sinai Health System, a seven-hospital health system in New York City and a driving force in the rapid technological innovations in healthcare, Responsive Health is dedicated to enabling the digital revolution in health. Responsive Health's flagship product, RxUniverse™, is the first enterprise-based digital health delivery system that enables physicians to prescribe evidence-based mobile health applications, wearables and therapeutics to patients at the point of care.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Pioneer in Digital Medicine Expands Northeast Presence

Secaucus, NJ -- (ReleaseWire) -- 04/19/2017 -- Responsive Health, a Mount Sinai spinoff and pioneer in enterprise-based digital medicine, today announced its entrance into the New Jersey healthcare market. As a result of this expansion, Responsive Health's transformative services in digital health will be generally accessible to health systems across New Jersey.

With this announcement, Responsive Health furthers its strategic efforts to introduce technologies throughout the United States that improve medical treatment outcomes for patients while reducing costs for healthcare providers. Health systems throughout New Jersey will benefit from Responsive Health's RxUniverse™ Digital Medicine Prescription™ system, which serves to engage patients and healthcare providers even after the typical hospital experience has ended.

"Today's announcement marks entry into the New Jersey healthcare market. It's also a serious step in Responsive Health's dedication to maintaining a presence in every major market in the United States," stated Eric Ditkowsky, Vice President of Value Transformation.

About Responsive Health
Responsive Health is defining the delivery of digital medicine. Founded as a startup from the Mount Sinai Health System, the largest health system in New York City and a driving force in the rapid technological innovations in healthcare, Responsive Health is dedicated to enabling the digital revolution in health. Responsive Health's flagship product, RxUniverse™, is the first enterprise-based digital health delivery system that enables physicians to prescribe evidence-based mobile health applications, wearables and therapeutics to patients at the point of care.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Mount Sinai Spin-Off Selects Startup Entrepreneur To Spearhead Development of Medical App Curation and Prescription Technology.

New York, NY -- (ReleaseWire) -- 11/16/2016 -- Responsive Health, startup spinoff from Mount Sinai, has selected Edward Berde as its new Chief Technology Officer. Berde will lead Responsive Health's launch of technologies that improve medical treatment outcomes while reducing costs, including Responsive's flagship product RxUniverse™ recently piloted in the Mount Sinai Health System. Berde is a serial entrepreneur and hands-on CTO with 20 years of experience in CTO, CEO, and leadership roles for numerous successful startups.

"Ed is an expert and leader in technology and business. He has tech at heart, but also has a love of entrepreneurship and a deep understanding of the business environment," says Ashish Atreja, MD, MPH, Responsive Health's co-founder and the Chief Technology Innovation and Engagement Officer and Director of the Sinai AppLab. "When Responsive Health spun off of the Mount Sinai Health System, we came out of the gate with close relationships with major healthcare players and insight into what providers need that most digital medicine startups struggle to achieve. We knew we needed someone with the expertise and drive to capitalize on that competitive advantage, and Ed Berde has all the qualifications we were searching for."

Berde joins Responsive Health from Business Consulting Solutions, a technology consulting firm which he co-founded and successfully ran for over 20 years. Berde's technological insight allowed Business Consulting to attain quick success and attract prestigious clients, including Guardian Life Insurance, Morgan Stanley, Horizon Blue Cross Blue Shield, Nestle, Lazard, and ADP.

An alumnus of Villanova, Cornell and Andersen Consulting, Berde's entrance into the startup world was as co-founder and CTO of Tips.com in 1999, where he developed the site into an informational search engine providing stock tips, health tips, product buying tips and more before successfully brokering an exit for the company in 2001. Berde's startup experience also includes directly running and growing the key departments of Client Environments and Client Onboarding for Rimini Street, overseeing employee and contractor resources based within the US and India, and onboarding over $16M of new contracts. Rimini Street, the leading global provider of independent enterprise software support, recently closed $125M of VC funding. Berde has also been a Director on the board of Clover Health Insurance, part of Clover Health, since its inception and continues to serve on the board today.

Berde's expertise in startups was nurtured by the New Jersey based TechLaunch incubator program, which he entered as the CEO, and later CTO of the startup Retail Shopping Systems. In just 3 months, Retail Shopping Systems created an Android-based hardware MVP, landed 5 stores and began rolling out prototype systems. "The TechLaunch experience is extraordinarily valuable since it provides a complete 'startup education' and a wealth of valuable connections," says Berde. "TechLaunch accomplishes that by bringing outstanding experts and mentors from the startup community who provide invaluable knowledge, especially the tools and tricks that allowed them to achieve success."

Asked about his motivation to join Responsive Health, Berde said, "There's a broad and urgent need by health providers to engage digital medicine for better health results. Right now the wrong medical apps are often used, and the right ones are overlooked. That hurts patients, providers, and payers. Responsive Health and Prescription Universe are ready to fix that."

About Responsive Health
Responsive Health is poised to radically change the delivery of digital medicine. Founded in 2016 as a startup from the Mount Sinai Health System, the largest health system in New York City and a driving force in the rapid technological innovations in healthcare, Responsive Health is dedicated to enabling the digital revolution in health. Responsive Health's flagship product, RxUniverse™, is the first enterprise-based digital medicine delivery system that enables physicians to prescribe evidence-based mobile health applications to patients at the point of care.

Information on Responsive Health and RxUniverse is available at ResponsiveHealth.org and RxUniverse.com, or find Responsive Health on Twitter @ResponsiveHlth and LinkedIn.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm